Nat Commun June 2023 PMID 37264016

The blood proteome of imminent lung cancer diagnosis.

Full text PDF Download social card

Mentions

Peak: 2 in Aug 2022

across 4 sources since Aug 2022

Extended reach

20,604

potential audience

Total likes

Video views

Mentions per month

Aug 2022 – Sep 2023

Where it's discussed

X / Twitter7 posts
Facebook2 posts
News2 articles
YouTube1 videos

AI synopsis

What people are saying

The discussions reflect a strong interest in the biomarker findings and their application in early lung cancer detection, with phrases like 'exciting use of proteomics' and 'study these biomarkers further.' The tone includes enthusiasm and curiosity about how technologies like Olink Proteomics could improve health outcomes, demonstrating deep engagement and recognition of the potential impact of the research.

AgreementModerate agreement

Most discussions acknowledge the significance of the findings, highlighting the potential of identified biomarkers and their connections to lung cancer processes.

InterestHigh interest

The posts demonstrate high interest, with many emphasizing new research methods, biomarker discovery, and potential clinical applications.

EngagementHigh engagement

Numerous discussions delve into technological aspects, such as use of proteomics platforms like Olink, and implications for early detection, indicating deep engagement.

ImpactModerate impact

Participants believe this research could influence early diagnosis strategies, though some posts focus on ongoing research rather than immediate clinical impact.

Abstract in brief

The study identified 36 blood proteins that are associated with an increased risk of developing lung cancer within three years, using samples taken before diagnosis from participants across the US, Europe, Singapore, and Australia.
Some of these proteins, like CA125 (MUC16) and CEACAM5 (CEA), were previously linked to lung cancer, while others are involved in processes like cell growth, immune response, and inflammation.
Mapping these proteins to cancer characteristics revealed that they often relate to key cancer processes such as tumor invasion, growth signaling, inflammation, and the formation of new blood vessels (angiogenesis).]

Read the full abstract

All mentions

Blood Proteome Indicators of Near-Term Lung Cancer Diagnosis

This study identified 36 blood proteins associated with increased lung cancer risk within three years, involving proteins linked to tumor invasion, growth, immune response, and angiogenesis, providing potential early…

STEM RTCL TV · Sep 23, 2023 57 views

MELISA Institute

@MELISAInstitute · X

Jul 18, 2023 · 2,091 followers View post →

TATAA Biocenter

@TATAA_CRO · X

Jul 3, 2023 · 58 followers View post →

LungOmics

@LungOmics · X

The blood proteome of imminent lung cancer diagnosis https://t.co/0xhZVkQ7AQ https://t.co/2KFO8eaodo

Jun 5, 2023 · 39 followers View post →

Jitendra Kr. Meena

@avertcancer · X

https://t.co/EG9qf6plUO https://t.co/zWM5GfxRkM

Jun 2, 2023 · 476 followers View post →

Tal Varsano

@varsanot · X

Sep 15, 2022 · 187 followers View post →

Mattias Johansson

@Mattias31 · X

RT @medrxivpreprint: The Blood Proteome of Imminent Lung Cancer Diagnosis https://t.co/gWnXpV8GQg #medRxiv

Aug 8, 2022 · 1 share · 227 followers View post →

medRxiv

@medrxivpreprint · X

The Blood Proteome of Imminent Lung Cancer Diagnosis https://t.co/gWnXpV8GQg #medRxiv

Aug 1, 2022 · 2 likes · 1 share · 17,465 followers View post →